Jason Hollar

Jason Hollar
Birthplace	United States
Nationality	American
Occupation	Corporate executive
Title	Chief Executive Officer and Director, Cardinal Health
Employer	Cardinal Health
Known for	Leading a business turnaround at Cardinal Health

Jason Hollar is an American business executive who serves as the Chief Executive Officer and a member of the Board of Directors of Cardinal Health, a Fortune 500 healthcare services and pharmaceutical distribution company headquartered in Dublin, Ohio. Under Hollar's leadership, Cardinal Health has undergone a significant business turnaround following a period in which the company's earnings had declined by approximately $300 million. Hollar has been credited with overhauling the company's operations through what he has described as a "ruthless" approach to strategic prioritization, ultimately guiding the firm toward record revenue. Cardinal Health, with revenues approaching $38 billion, operates as one of the largest healthcare companies in the United States, providing pharmaceutical and medical product distribution services. Hollar's tenure has been marked by a combination of strategic acquisitions, organic growth initiatives, and a focus on medication affordability and access. He has also engaged with public officials and media on topics including healthcare policy and environmental responsibility at the company's facilities.

Career

Cardinal Health

Jason Hollar serves as Chief Executive Officer and Director of Cardinal Health, a major healthcare services company that ranks among the Fortune 500. The company, headquartered in Dublin, Ohio, is a significant player in the pharmaceutical distribution and healthcare services sector, with revenues of approximately $38 billion.

Business Turnaround

When Hollar assumed leadership of Cardinal Health, the company was facing a substantial decline in financial performance, with earnings having fallen by approximately $300 million. Hollar undertook what Fortune magazine characterized as a comprehensive overhaul of the business, adopting a strategy he described as "ruthless" in its focus on operational improvements and strategic realignment. In a 2025 interview with Fortune, Hollar indicated that his approach to the turnaround was supported by the company's workforce, stating that "people want to win," suggesting that employees responded positively to the clarity of direction and the pursuit of improved performance.

The turnaround effort yielded significant results. By early 2026, Hollar reported that Cardinal Health had achieved record revenue, a level of growth that he acknowledged would have been difficult for investors to anticipate. In a February 2026 interview with The Business Journals, Hollar stated: "If I would have told investors three years ago that we'd grow like this, they wouldn't have believed me." Hollar also emphasized the importance of the company's Central Ohio base in achieving these results, highlighting the region's role in supporting the company's operations and growth trajectory.

Strategic Acquisitions and Organic Growth

Under Hollar's leadership, Cardinal Health has pursued a dual strategy of strategic acquisitions and organic growth. The company's at-Home Solutions business, in particular, has benefited from this approach. According to HME News, Cardinal Health's acquisition of Advanced Diabetes Supply (ADS) contributed significantly to the growth of the at-Home Solutions segment, complementing the company's broader organic expansion efforts. The company's strategy under Hollar has sought to balance the integration of acquired businesses with the development and expansion of existing operations, aiming to create sustainable long-term growth across its portfolio of healthcare services.

Healthcare Policy and Medication Affordability

Hollar has been an active voice on healthcare policy matters, particularly regarding medication affordability and access. In an October 2025 appearance on Fox Business's The Claman Countdown, Hollar discussed the importance of maintaining access to affordable medications, addressing topics including the ongoing debate over Affordable Care Act (Obamacare) subsidies and their impact on healthcare affordability for consumers. During the appearance, Hollar emphasized that it was "important to make sure access and affordability continues to be maintained," positioning Cardinal Health as a stakeholder invested in the broader healthcare ecosystem and the ability of patients to obtain necessary medications.

Environmental and Community Issues

In December 2025, Hollar became the subject of a congressional inquiry when U.S. Representative Veronica Escobar of Texas's 16th congressional district sent a letter to him in his capacity as Cardinal Health's CEO. The letter expressed concern about toxic ambient air emissions at a Cardinal Health facility in El Paso, Texas, following an investigation published by El Paso Matters. Congresswoman Escobar requested answers from Hollar and Cardinal Health regarding the reported emissions and their potential impact on the surrounding community. The inquiry highlighted the environmental oversight responsibilities faced by leaders of large-scale healthcare distribution and manufacturing companies.

Stock Transactions

In August 2025, it was reported that Hollar had sold a significant number of shares in Cardinal Health. According to Simply Wall St, some shareholders expressed concern over the stock sale, which is a matter of public record for executives of publicly traded companies. Such transactions by corporate executives are required to be disclosed under U.S. Securities and Exchange Commission regulations and are routinely monitored by investors and financial analysts as potential indicators of executive sentiment regarding company performance and valuation.

Leadership Style

Hollar's leadership approach at Cardinal Health has been characterized by a willingness to make decisive and sometimes difficult strategic choices. His self-described "ruthless" approach to the company's turnaround involved a thorough reassessment of the company's business lines and operational priorities. In his Fortune interview, Hollar discussed the importance of employee buy-in during periods of significant organizational change, noting that workers responded positively to a clear strategic direction and a focus on winning in the marketplace. He characterized the employee response as supportive, suggesting that the workforce recognized the necessity of the changes and appreciated the transparency with which they were communicated.

As a member of Generation X, Hollar has been identified among a cohort of corporate leaders who have assumed top roles at major American companies. Fortune described him as a "Gen X boss" leading a Fortune 500 healthcare giant, placing him within a broader generational narrative of executive leadership in corporate America.

Public Engagement

Beyond his corporate responsibilities, Hollar has engaged with various public stakeholders in his role as the leader of one of America's largest healthcare companies. His appearances on business media platforms such as Fox Business have provided him with opportunities to discuss the healthcare industry's challenges and Cardinal Health's perspective on policy matters affecting pharmaceutical distribution and patient access to medications.

The congressional inquiry from Congresswoman Escobar in December 2025 also placed Hollar in the position of responding to government oversight regarding environmental matters at Cardinal Health facilities, reflecting the broader accountability expectations placed on CEOs of major corporations operating in regulated industries.

Hollar has also spoken publicly about the role of Cardinal Health's geographic base in Central Ohio in supporting the company's operations and growth. In his February 2026 interview, he specifically highlighted the importance of the Columbus, Ohio, metropolitan area to the company's ability to attract talent and sustain its business operations at a level sufficient to achieve record revenues.

Recognition

Jason Hollar's leadership of Cardinal Health has attracted attention from major business media outlets. Fortune magazine profiled his turnaround of the company in a July 2025 feature article that examined how he reversed a $300 million earnings decline and guided the company to a period of significant growth. The Business Journals featured Hollar in a February 2026 interview focused on the company's record revenue performance and the role of its Central Ohio headquarters in achieving those results.

Cardinal Health's position as a Fortune 500 company and one of the largest healthcare distribution firms in the United States ensures that its CEO is a subject of regular coverage in financial and business media. Hollar's stock transactions, public statements on healthcare policy, and corporate performance have all been the subject of reporting by outlets including Simply Wall St, Fox Business, and HME News.

Legacy

While Jason Hollar's tenure at Cardinal Health is ongoing, his impact on the company has been substantive. The business turnaround he led—reversing a significant earnings decline and ultimately guiding the company to record revenue—represents one of the more notable corporate turnarounds in the American healthcare sector in recent years. His strategic approach, combining acquisitions such as Advanced Diabetes Supply with organic growth initiatives, has reshaped Cardinal Health's business portfolio, particularly in the at-Home Solutions segment.

Hollar's emphasis on medication affordability and access has also positioned Cardinal Health as a participant in broader healthcare policy discussions at a time when drug pricing and healthcare access remain central issues in American public policy. The environmental inquiry from Congress regarding a Cardinal Health facility in El Paso has highlighted the ongoing challenges that leaders of large healthcare distribution companies face in balancing operational efficiency with environmental and community responsibilities.

His leadership has demonstrated the potential for decisive strategic action to transform the performance of a major healthcare company, and his public statements regarding employee engagement during periods of organizational change have contributed to broader discussions about corporate leadership and workforce management in the Fortune 500.